What medication research is being done to stop or reverse Parkinson's disease progression?
Currently, there's no cure for Parkinson's disease, but researchers are actively testing new medications that aim to slow disease progression rather than just manage symptoms.
Two promising drugs are currently in phase 2 clinical Show Full Answer
What medication research is being done to stop or reverse Parkinson's disease progression?
Currently, there's no cure for Parkinson's disease, but researchers are actively testing new medications that aim to slow disease progression rather than just manage symptoms.
Two promising drugs are currently in phase 2 clinical trials:
- Prasinezumab: An intravenous (IV) medication given once every four weeks, with study completion expected in 2026
- UCB0599: An oral medication being tested, with trial completion scheduled for 2024
Beyond these specific drugs, researchers are exploring several innovative treatment strategies:
- Calcium channel blockers (typically used for high blood pressure) to potentially slow Parkinson's progression
- Immune system modulation approaches, including a drug called sargramostim
- Gene therapy delivered through harmless viruses to protect dopamine-producing cells
The future of Parkinson's treatment focuses on slowing degeneration, prolonging independence, and potentially addressing symptoms before they become severe. Learning more about the genetic aspects of Parkinson's could help develop treatments that intervene earlier in the disease process.
While these advances are encouraging, it's important to discuss current treatment options with your neurologist or movement disorder specialist to manage your symptoms effectively while research continues.
February 5
Join
Your Privacy Choices
